Bd launches new robotic system to automate clinical flow cytometry

Bd facsduet™ premium system leverages robotics to automate sample preparation for greater standardization in clinical flow cytometry diagnostics franklin lakes, n.j. , june 12, 2023 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced the worldwide commercial launch of a new automated instrument that prepares samples for clinical diagnostics using flow cytometry, enabling a complete "walkaway" workflow solution designed to improve standardization and reproducibility in cellular diagnostics.
BDX Ratings Summary
BDX Quant Ranking